Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the …
M Schlegel, S Bachmann - Medicina, 2024 - mdpi.com
(1) Background and Objectives: The COVID-19 pandemic influenced the management of
patients with immune-mediated rheumatic and musculoskeletal diseases (imRMDs) in …
patients with immune-mediated rheumatic and musculoskeletal diseases (imRMDs) in …
[PDF][PDF] Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: Experience of a single center
Results: A total of 181 CIRD patients were enrolled. Rheumatoid arthritis was the most
common disease requiring intravenous immunosuppressive treatment followed by axial …
common disease requiring intravenous immunosuppressive treatment followed by axial …
[HTML][HTML] Attitudes of patients with a rheumatic disease on drug use in the COVID-19 pandemic
BN Coskun, B Yagiz, Y Pehlivan… - Advances in …, 2021 - SciELO Brasil
Background: Anti-rheumatic drugs can increase the predisposition to infection, and patients
may be unaware of continuing their treatment during the COVID-19 pandemic. Objective …
may be unaware of continuing their treatment during the COVID-19 pandemic. Objective …
Impact of the first SARS-CoV-2 lockdown on adherence to biological treatment in patients with immune-mediated inflammatory diseases in the Netherlands
R van der Groef, PHP de Jong, DJ Hijnen… - Patient preference …, 2023 - Taylor & Francis
Purpose During the SARS-CoV-2 pandemic, national and international societies have
recommended continuing biological agents in patients with immune-mediated inflammatory …
recommended continuing biological agents in patients with immune-mediated inflammatory …
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
Objectives To describe the status of using biological Disease Modifying Anti Rheumatic
Drugs (bDMARDs) to treat rheumatoid arthritis (RA) and related factors. In addition, the study …
Drugs (bDMARDs) to treat rheumatoid arthritis (RA) and related factors. In addition, the study …
Influence of the COVID-19 Pandemic on the Treatment of immune mediated Rheumatic and Musculoskeletal Diseases during the first pandemic period: A Systematic …
M Schlegel, S Bachmann - 2024 - preprints.org
Abstract Background and Objectives: The COVID-19 pandemic influenced the management
of patients with immune mediated rheumatic and musculoskeletal diseases (imRMDs) in …
of patients with immune mediated rheumatic and musculoskeletal diseases (imRMDs) in …
Effects of the COVID-19 Pandemic in Unvaccinated Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients Using Disease-modifying …
K Sarı, FÜ Özkan, İ Aktaş… - Medical Journal of …, 2023 - search.ebscohost.com
Objective: To investigate the health status, experiences, and status of contracting or being
affected poorly by coronavirus disease-2019 (COVID-19) in patients using disease …
affected poorly by coronavirus disease-2019 (COVID-19) in patients using disease …